(Q35111654)

6 August 2017

title

E-4695, a new C-7 azetidinyl fluoronaphthyridine with enhanced activity against gram-positive and anaerobic pathogens (English)

1 reference

6 August 2017

main subject

gram-positive bacteria

0 references

author name string

Guinea J

1

1 reference

6 August 2017

Gargallo-Viola D

2

1 reference

6 August 2017

Robert M

3

1 reference

6 August 2017

Tudela E

4

1 reference

6 August 2017

Xicota MA

5

1 reference

6 August 2017

Garcia J

6

1 reference

6 August 2017

Esteve M

7

1 reference

6 August 2017

Coll R

8

1 reference

6 August 2017

Pares M

9

1 reference

6 August 2017

Roser R

10

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 1995

1 reference

Antimicrobial Agents and Chemotherapy

6 August 2017

published in

1 reference

6 August 2017

volume

39

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

413-421

1 reference

In vitro and in vivo antibacterial activities of E-4868, a new fluoroquinolone with a 7-azetidin ring substituent

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

In vitro and in vivo activity of DL-8280, a new oxazine derivative

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

In vitro antibacterial activity of E-3604, a new 6-fluoroquinolone, on clinical isolates

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

In vitro and in vivo activity of NY-198, a new difluorinated quinolone

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strains

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

In vitro activity of PD 127,391, an enhanced-spectrum quinolone

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

WIN 57273, a new fluoroquinolone with enhanced in vitro activity versus gram-positive pathogens

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

Comparative in vitro and in vivo activities of six new monofluoroquinolone and difluoroquinolone 3-carboxylic acids with a 7-azetidin ring substituent

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3-methyl-azetidinyl tricyclic fluoroquinolone

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

In vitro evaluation of E-4695, a new fluoro-naphthyridine

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

In vitro activities of three of the newer quinolones against anaerobic bacteria

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162552

[A new synthetic antibacterial : 1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-1, 4-dihydroquinolin-3-carboxylic acid (1589 R.B.)]

9 July 2018

1 reference

12 December 2020

Novel amino-substituted 3-quinolinecarboxylic acid antibacterial agents: synthesis and structure-activity relationships

1 reference

12 December 2020

Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents

1 reference

12 December 2020

In vitro antibacterial activity of irloxacin (E-3432) on clinical isolates

1 reference

12 December 2020

Antimicrobial activity of E-4441, a representative azetidine quinolone

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.39.2.413

1 reference

6 August 2017

1 reference

6 August 2017

1 reference